a r t i c l e s
Immunoglobulin E (IgE) antibodies play a central role in allergic disease 1 . They recognize allergens in two very different contexts, either in a membrane-bound form as part of the B-cell receptor (BCR) or bound to the receptor FcεRI on effector cells such as mast cells and basophils. FcεRI-bound IgE causes long-term sensitization of these cells, and cross-linking by allergen leads to cell degranulation, release of inflammatory mediators and an immediate allergic response. Disruption of the IgE-FcεRI interaction is a validated strategy for therapeutic intervention in allergic diseases including asthma: an anti-IgE monoclonal IgG antibody, omalizumab (Xolair, Novartis Pharmaceuticals), inhibits IgE binding to FcεRI and is effective in the treatment of severe persistent asthma and other allergic diseases 2 .
IgE consists of a dimer of two identical heavy and two identical light chains, but unlike IgG, in which the antigen-binding Fab region is separated from the receptor-binding Fc region by a flexible hinge, IgE contains an additional disulfide-linked pair of domains, (Cε2) 2 , forming a (Cε2-Cε3-Cε4) 2 dimer 1 . Fluorescence depolarization studies to assess segmental flexibility have shown IgE to be less flexible than IgG [3] [4] [5] [6] , and Förster resonance energy transfer (FRET) studies that determined distances both intramolecular and to the membrane led to a model of a compact, bent structure for IgE both when free in solution and when bound to FcεRI [6] [7] [8] [9] . Although an extended model was also proposed 10 , X-ray and neutron-scattering studies in solution confirmed that IgE and IgE-Fc adopt a compact, bent structure 11, 12 . An acutely and asymmetrically bent conformation was subsequently observed in the crystal structure of IgE-Fc (Fig. 1a) 13 . In this bent structure, the (Cε2) 2 domain pair folds back onto the Cε3-Cε4 domains, forming an extensive intramolecular interface (1,520 Å 2 ). The subsequent structure of the complex of IgE-Fc bound to the extracellular domains of the FcεRI α-chain (sFcεRIα) revealed an even more acute bend upon receptor binding 14 , consistent with FRET and fluorescence-depolarization studies that indicated reduced segmental flexibility 6, 15, 16 . At this point the existence of an extended conformation of IgE-Fc was all but dismissed.
Although the Cε2 domains are not directly involved in binding FcεRIα, they do contribute to the kinetics of the interaction, decreasing both the association and dissociation rate constants 14, 17 . Interest in their structural and functional roles intensified following the discovery that the Fab fragment of omalizumab binds to a partially unbent conformation of IgE-Fc, as detected in a FRET experiment 16 . This first indication that IgE-Fc may not always be bent raises the question of whether the molecule transiently explores more extended conformations, and perhaps even flips between bent structures with the Cε2 domains folded back on opposite sides of the Cε3-Cε4 domains. Trapping of transiently populated conformational states has previously been achieved by antibody binding 18 , and so to explore the potential conformational diversity of IgE-Fc, we generated an IgG antibody Fab fragment that binds to IgE-Fc (anti-ε-chain Fab; aεFab) and discovered that it captured an extended conformation.
RESULTS

Structure of IgE-Fc bound by two aεFab fragments
The aεFab-IgE-Fc crystal structure was solved at 2.9 Å resolution ( Table 1) . The IgE-Fc adopts a fully extended conformation, with two aεFab molecules bound one on each side of the almost perfectly symmetrical IgE-Fc (aεFab 1 -IgE-Fc-aεFab 2 , with superscripted numbers denoting the two aεFab molecules, Fig. 1b,c) . Compared with the structure of IgE-Fc alone, the molecule has undergone a drastic 'unbending' a r t i c l e s of 120° (Fig. 1a, c) , completely losing the extensive intramolecular interface between the Cε2 and Cε3-Cε4 domains. This unbending seems to derive largely from movements in the Cε2-Cε3 linker region, in particular residues Pro333, Arg334 and Gly335 (Supplementary  Video 1) . Although the Cε2 domains show the greatest structural change, the Cε3 domains also undergo considerable movement. Conformational flexibility has been seen in a number of structures of the Fcε3-4 subfragment of IgE-Fc, with the Cε3 domains described as 'open' or 'closed' (together with a 'swinging' of one Cε3 domain relative to the other, Supplementary Fig. 1a ) 19 . In the bent structure of IgE-Fc alone, one Cε3 is open (chain B) and one is closed (chain A), whereas in the extended conformation of IgE-Fc revealed here, both Cε3 domains adopt an open conformation (Supplementary Fig. 1b ). Cε3 A (the Cε3 domain of chain A) thus moves more than Cε3 B (the Cε3 domain of chain B) upon aεFab binding, with a change in the Cε3-Cε4 interdomain angle of 15°. The (Cε4) 2 pair are unchanged upon complex formation. Such is the symmetry of the IgE-Fc in the complex that the local two-fold axes of all three domain pairs are virtually coincident.
As a result of this symmetry, the two aεFab interfaces are structurally equivalent (each ~1,400 Å 2 ), mainly involving contact of the aεFab heavy and light chains with Cε3, but with a small interaction with Cε2 (Supplementary Fig. 2a) . Each aεFab molecule principally contacts a single IgE-Fc chain (aεFab 1 to IgE-Fc A and aεFab 2 to IgE-Fc B ), with the exception of a 315 Å 2 interface with the Cε2-Cε3 linker region (including Ser331 and Asn332) of the other IgE-Fc chain (Supplementary Fig. 2b ). The 'hot spot' of the aεFab-binding surface on IgE-Fc appears to center on Cε3 residue Arg393, which protrudes into a pocket at the interface of the heavy and light chains of aεFab ( Supplementary Fig. 2c ), forming a salt bridge (to Asp121 of the heavy chain) and hydrogen bonds (to Glu109 and Asn54 of the light chain; Supplementary Fig. 2d,e) . The adjacent Cε3 residues also contribute extensively (Supplementary Fig. 2c) .
Comparison of the aεFab 1 -IgE-Fc-aεFab 2 complex with free IgE-Fc shows that the latter presents only one aεFab binding site. When superimposed on the Cε3 A domains, the aεFab-binding hot spot is both unchanged and accessible in bent IgE-Fc, making it a likely point for aεFab engagement. However, the Cε2 domains in the bent structure completely occlude aεFab binding to the other side of the molecule (Cε3 B ) and would have to move substantially toward an extended conformation before aεFab access would be possible (Fig. 1a,b) .
Molecular-dynamics simulation of IgE-Fc unbending
The crystal structure of the aεFab 1 -IgE-Fc-aεFab 2 complex reveals that an extended conformation of IgE-Fc is feasible. The key question, however, is whether this is just a consequence of aεFab binding, or whether it (or other extended conformations) exists in solution as an intrinsic property of IgE. If the latter, then could the Cε2 domain pair make the transition from one side of the Cε3-Cε4 domains to the other via an extended structure-that is, 'flip' between two symmetrically related bent conformations (Supplementary Video 2)? We used metadynamics, an enhanced molecular-dynamics (MD) method [20] [21] [22] [23] , to produce a detailed atomistic simulation of IgE-Fc unbending and its extended conformations. This simulation provides a free-energy surface (potential of mean force) calculated and presented in terms of the two principal components of the molecule's unbending dynamics ( Fig. 2a and Supplementary Fig. 3) .
The lowest energy state is a well-defined minimum that corresponds to the bent conformation seen in the free IgE-Fc crystal structure 13 ( Fig. 2, conformation 1) . A number of other energy minima may be seen at ~20 kJ/mol above that of the bent state, suggesting possible paths (one of which is indicated, Fig. 2a ) leading away from the bent structure toward more extended conformations (Fig. 2a,b , conformations 2 and 3). The dynamic simulation identifies another minimum (Fig. 2a, conformation 4 ) symmetrically related to conformation 3 and separated by a small energy barrier that corresponds to a linear conformation (indicated in Fig. 2c) . As IgE-Fc crosses this low barrier, the Cε2 domain pair passes from one side of the molecule to the other. Having traversed the midpoint (x = 0 in Fig. 2a) , the Cε2 domains may fold onto the other side of the Cε3-Cε4 domains, completing a full transition from one The shift from the proposed pathway corresponds to twisting of (Cε2) 2 , presumably stabilized by aεFab binding. Although comparison of the bent and extended crystal structures identified Pro333, Arg334 and Gly335 in the Cε2-Cε3 linkers as the residues that undergo the most substantial structural rearrangement accompanying (Cε2) 2 domain motions, the simulation revealed additional changes around Gly335 of the A chain and Asn332 of the B chain; smaller movements in the Cε3-Cε4 linker around Ser437 of the A chain are associated with the change in the interdomain angle. The simulation additionally revealed a twisting of (Cε2) 2 relative to the Cε3-Cε4 domains during the unbending process. The mechanism by which domain rearrangements and unbending occur may not simply be rigid-body movements facilitated by linkers that undergo changes from one ordered structure to another ('mechanical hinges'), but may involve order-disorder transitions as described in other systems [24] [25] [26] . Local disorder or unfolding and re-folding within linkers, or regions of the domains themselves, can facilitate large-scale conformational changes in proteins, providing entropic compensation to reduce high enthalpic barriers 26, 27 . We can now search for evidence of such order-disorder transitions within the wealth of structural information generated by this simulation, but such detailed mechanistic analyses are beyond the scope of the present manuscript.
Regardless of the mechanism, the highest barrier encountered in a complete flip, and thus the rate-determining step, is clearly that involved in leaving the bent conformation; once this is achieved, the barriers to exploring the extended conformations are relatively low. However, the energy difference between the wells corresponding to the bent and extended conformations is such that the fraction of molecules in the extended state will be very small, consistent with the experimental observation that the bent conformation predominates in solution 9, 12, 16 .
a«Fab binding to IgE-Fc by isothermal titration calorimetry
One way to establish whether IgE-Fc has an intrinsic capacity to unbend in solution is to determine the number of available aεFab binding sites. If IgE-Fc is rigidly and exclusively bent, only one site will ever be accessible, but if it is flexible, then two sites will be accessible. We therefore studied the interaction between aεFab and IgE-Fc by isothermal titration calorimetry (ITC) and compared this with the binding of aεFab to Fcε3-4 which, lacking the Cε2 domains, always has two accessible sites. The results for both IgE-Fc and Fcε3-4 are similar, showing that both molecules do indeed present two binding sites ( Fig. 3a,b) . The K d values for aεFab binding to IgE-Fc and Fcε3-4 were found to be 40 nM and 50 nM, respectively (Fig. 3a,b and Table 2 ), but in order to distinguish between the binding affinities of the two aεFab molecules, the ITC experiment was then conducted by titrating aεFab into either IgE-Fc or Fcε3-4 ( Fig. 3c,d ). This revealed K d values for IgE-Fc of 76 nM and 1.5 µM for the first and second binding sites, respectively (with similar values for Fcε3-4; Table 2 ); the second aεFab clearly binds more weakly than the first, and small ∆H values indicate that binding of both aεFab 1 and aεFab 2 is entropically driven.
Assembly mechanism of a«Fab 1 -IgE-Fc-a«Fab 2 in solution The observed 2:1 stoichiometry demonstrates that in solution IgE-Fc can adopt the extended structures needed to expose both aεFab binding sites. The binding of aεFab 1 mediates an allosteric change in IgE-Fc, which may occur through induced fit 28 , conformational selection 29 or a combination of both mechanisms 30 . In order to investigate the assembly mechanism of the aεFab 1 -IgE-Fc-aεFab 2 complex, we monitored the intrinsic tryptophan fluorescence upon binding in stopped-flow kinetic experiments. When IgE-Fc (or Fcε3-4) was in excess over aεFab, thus restricting the stoichiometry of the aεFab-IgE-Fc (or Fcε3-4) complex to 1:1, a single binding event was observed (Supplementary Fig. 4a,b) . This has a fast association rate constant and a dissociation rate too slow to measure by this technique ( Table 2 ). The observation of monophasic kinetics implies that no conformational change is coupled to formation of aεFab 1 -IgE-Fc (although we cannot rule out the possibility of such a change occurring on a timescale faster than that of the experiment).
When repeated with aεFab in excess over IgE-Fc, two-step binding was observed for both IgE-Fc and Fcε3-4 ( Supplementary Fig. 4ab ), consistent with not only aεFab 1 binding faster than aεFab 2 , but also the difference in affinities of the two sites determined by ITC ( Table 2) . Furthermore, a linear concentration dependence for the observed rate constants (k obs ) of the binding of both aεFabs to either IgE-Fc or Fcε3-4 suggests that aεFab 1 does not cause a conformational change (such as unbending of IgE-Fc) that is rate-limiting for aεFab 2 binding ( Supplementary Fig. 4c-f) . In the absence of any evidence for an induced conformational change, our results are most consistent with a conformational selection model, with extended structures selected from a dynamic population of IgE-Fc conformations.
In order to test whether aεFab 1 npg a r t i c l e s bent structures, we carried out intramolecular FRET, with IgE-Fc labeled with donor and acceptor fluorophores in the Cε2 and Cε4 domains, respectively. Upon titration into labeled IgE-Fc, a concentration of aεFab sufficient to occupy the first binding site resulted in a partial decrease of FRET signal (Fig. 3e) . This implies that under these conditions the IgE-Fc is not exclusively extended, as would be expected if aεFab 1 binding caused full linearization; nor does IgE-Fc remain bent. Taken together with the stopped-flow data (linear concentration dependence of the kinetics of aεFab 2 binding and similar behavior of IgE-Fc and Fcε3-4), the FRET data show that IgE-Fc in the aεFab 1 -IgE-Fc complex remains conformationally dynamic. It is only upon saturation of the second binding site that no further reduction in the FRET signal occurs (Fig. 3e) , corresponding to a fully extended IgE-Fc. These results are summarized in Figure 4 , which depicts a possible mechanism for the formation of the aεFab 1 -IgE-Fc-aεFab 2 complex (see also Supplementary Video 3). Initially, IgE-Fc is predominantly bent in solution (consistent with X-ray and neutron scattering 12 and FRET 16 ), but it may transiently adopt extended conformations such as those identified in the MD simulation (Fig. 4a) . Next, aεFab 1 engages IgE-Fc in the bent or an extended conformation. With aεFab 1 bound, IgE-Fc can still flex between bent and extended conformations (Fig. 4b) . Finally, when IgE-Fc is transiently extended, aεFab 2 engages and completes the aεFab 1 -IgE-Fc-aεFab 2 complex (Fig. 4c) .
Effect of a«Fab on Fc«RI binding
We have demonstrated the existence of a range of conformational states available to IgE-Fc, but how do these different states affect binding of IgE to FcεRIα? Receptor-bound IgE-Fc is even more acutely bent than free IgE-Fc, and interacts with the receptor with high affinity (K d ~ 0.1 nM) 1 through two subsites, one on each Cε3 domain (Fig. 5a) 14, 31 . In the extended conformation of IgE-Fc that results from aεFab binding, both of the FcεRIα-binding subsites are disrupted (Fig. 5b) . In subsite 1 on IgE-Fc A , Arg334 forms a critically important salt bridge with FcεRIα, but this residue is part of the linker that undergoes structural rearrangement upon extension of (Cε2) 2 , and is no longer in a position to engage in FcεRIα binding. The second subsite on IgE-Fc B involves a proline (Pro426 of Cε3 B ) sandwiched between two tryptophan residues (Trp87 and Trp110 of FcεRIα), but this proline moves 6 Å away from its receptor-bound conformation in the aεFab complex. Even if receptor engagement with Pro426 of subsite 2 alone occurs, modeling of sFcεRIα in this position on the extended IgE-Fc results in clashes between both Cε3 A and (Cε2) 2 of IgE-Fc with the receptor (Fig. 5c) .
Thus, aεFab binding allosterically prevents FcεRIα binding to IgE-Fc by trapping the molecule in an extended state that cannot engage with receptor. But does aεFab 1 alone compete with FcεRIα binding to bent IgE-Fc? We compared the aεFab-bound structure with that of IgE-Fc bound to sFcεRIα. Modeling of a single aεFab Table 2 ). Molar ratio 1:1 corresponds to an aεFab 1 -IgE-Fc complex, and 2:1 corresponds to the aεFab 1 -IgE-Fc-aεFab 2 
npg a r t i c l e s
onto the IgE-Fc-sFcεRIα structure shows that although the residues involved in the two interactions are distinct, the aεFab and receptor molecules clash (Fig. 5d) . Therefore, aεFab 1 and sFcεRIα compete for binding to the bent form of IgE-Fc. This was confirmed using SPR to determine whether aεFab 1 alone is capable of inhibiting sFcεRIα binding to IgE-Fc, or whether aεFab 2 is required to trap the molecule in an extended conformation before inhibition occurs. aεFab was first immobilized on an SPR biosensor surface and binding of IgE-Fc was tested over a range of concentrations (Supplementary Fig. 5a ). The K d of aεFab 1 binding to IgE-Fc was found to be 95 nM (±6 nM), in agreement with ITC results (Table 2) . Subsequently, binding of aεFab 2 to form aεFab 1 -IgE-Fc-aεFab 2 was characterized. After immobilization of aεFab on the SPR biosensor surface, IgE-Fc was flowed over the chip to form the aεFab 1 -IgE-Fc complex, followed by aεFab 2 to complete the trimolecular complex (Supplementary Fig. 5b ). On the basis of an equilibrium analysis, the K d of aεFab 2 binding was estimated to be 1.4 µM (±0.1 µM), again in good agreement with ITC results. To determine how binding of aεFab 1 to IgE-Fc affects the binding of sFcεRIα, the aεFab 1 -IgE-Fc complex was first formed as described above, and before this complex could dissociate, sFcεRIα was passed over the surface in increasing concentrations. No binding of sFcεRIα was observed up to a concentration of 1 µM, confirming that binding of a single aεFab is sufficient to inhibit receptor binding to IgE-Fc (Supplementary Fig. 5c ). aεFab thus inhibits receptor binding by a steric mechanism when IgE-Fc is bent and also allosterically when IgE-Fc is extended.
Modeling membrane-bound IgE
We previously modeled the conformations accessible to the Fab arms of IgE using the bent, receptor-bound structure of IgE-Fc 16 . This revealed little overlap between the spaces explored by the two Fab arms, one of which was directed away from, the other parallel to, the membrane, consistent with both allergen recognition and receptor cross-linking (Fig. 6a,b) . However, it is difficult to see how a rigidly bent IgE molecule could function in allergen recognition in the BCR because the Fab arms would be directed toward the membrane (Fig. 6c) . To test this, we oriented the ensemble of whole IgE models reported previously 16 in a membrane-bound position, with a spacer to represent the extra membrane-proximal domains (EMPD) that separate the C termini of the Cε4 domains from the membrane (Fig. 6d) . Irrespective of spacer length (the EMPD structure is unknown), the Fab arms only explore space close to the membrane. To determine how an extended conformation of IgE-Fc would present the Fab arms, we implemented the same method of model generation and positioned 2,000 models of IgE relative to the membrane. npg a r t i c l e s conformations orient the Fab arms away from membrane, optimally for allergen binding (Fig. 6e,f) .
DISCUSSION
Ever since the first model of a bent structure for IgE [6] [7] [8] [9] , the determination of the acutely and asymmetrically bent IgE-Fc by X-ray crystallography 13 and demonstration by X-ray solution scattering and FRET that this structure predominates in solution 9, 11, 12, 16 , the idea that the (Cε2) 2 domain pair might flip from one side to the other has been only a tantalizing possibility. Fluorescence depolarization analyses of segmental flexibility in IgE and electron microscopy (EM) of immune complexes had shown that the molecule was less flexible than IgG [3] [4] [5] [6] 15, 32 , and in the crystal structure of its complex with sFcεRIα 14 , IgE-Fc was found to be even more acutely bent, consistent with FRET studies in solution 16 and when receptor-bound on cells 6 . Only the binding of omalizumab Fab to IgE-Fc in solution, monitored by FRET, indicated that a partial unbending of IgE-Fc was possible 16 . The observation of a fully extended IgE-Fc in the aεFab complex reported here was therefore a considerable surprise. We have now demonstrated by MD simulation and solution biophysical studies that IgE-Fc can indeed unbend and adopt a range of transiently extended conformations, suggesting a possible pathway for the Cε2 domains to flip from one side of the Cε3-Cε4 to the other. The degree of flexibility described for IgE-Fc here is unlike any reported for other antibody classes. Flexibility between the V and C domains in Fab fragments ('elbow bending') and within the hinge separating Fab and Fc regions in IgG antibodies is well documented, but conformational variation within the Fc has to date been limited to minor changes in the orientation of the Cγ2 domains of IgG 33 or the Cε3 domains of IgE 19 . Open and closed conformations for the latter have been reported in structures of IgE-Fc and Fcε3-4 both free and when bound to either sFcεRIα 14, 31 or to sCD23, the soluble IgE-binding domain of the 'low-affinity' receptor on B cells 34 . The conformational diversity in IgE-Fc reported here is substantially greater than previously seen in Fc structures. In fact, the earlier fluorescence depolarization data on IgE should be reinterpreted in terms of bending at the Cε2-Cε3 linker regions in addition to bending between Fab and Fc.
IgM, an evolutionary precursor of IgE, also contains a domain pair, (Cµ2) 2 , rather than a flexible hinge, and is known to undergo substantial conformational changes. Free in solution it adopts planar, star-shaped pentameric or hexameric structures, as determined by small-angle X-ray and neutron scattering and EM studies 35, 36 , but when bound by Fab arms of two or more subunits to an antigenic surface, it adopts 'table-like' structures with the disc of penta-or hexameric Fc regions at 90° to the Fab arms 35 . However, the location of the bend in the molecule is unknown. Modeling of IgM structures against solution-scattering data placed the bend between Cµ2 and Cµ3 (ref. 36) , as suggested earlier in fluorescence depolarization studies 37 , whereas later modeling against cryo-EM data was consistent with bending between Cµ1 and Cµ2 (ref. 38) . Recent crystallographic analyses of individual IgM-Fc domains leaves the question unresolved 39 . It is clear, however, that at least in the context of the polymeric structures, the monomeric IgM subunit can adopt either linear or bent conformations, and if the flexibility in IgE is evolutionarily related to that of IgM, bending of the latter would be predicted to occur between Cµ2 and Cµ3. Conformational change in IgM is critical for function, as dislocation upon antigen binding reveals sites for complement binding that are hidden in the planar structures. There is therefore a precedent for an extended conformation of an antibody with the 'additional' , hinge-replacing domains that has a clear biological function.
That IgE evolved conformational diversity to allow both a compact bent and an ensemble of extended, flexible structures may be understood in terms of its allergen-binding functions in two distinct contexts. Bound to FcεRI on effector cells (mast cells, basophils or antigen-presenting cells), bent IgE presents its Fab arms appropriately for allergen recognition and cross-linking 16 , which triggers the allergic response (Fig. 6a,b) . In contrast, as part of the BCR, in which npg a r t i c l e s the role of membrane IgE is to capture allergen and ensure B-cell survival and proliferation, only an extended molecule presents the Fab arms optimally for detection of allergen ( Fig. 6c-f) . One recognized advantage of conformational flexibility is 'fly casting': that is, the ability to sample a greater range of conformational space and make ligand (allergen) capture more effective 40 . Conventional depictions of the BCR for all antibody classes show extended Fab arms, and the extended IgE-Fc structure reported here demonstrates that such a conformation is feasible.
In the extensively studied IgM BCR, which contains a single IgM subunit, it has been assumed, in the absence of a crystal structure, that IgM adopts an extended conformation. It has also been proposed that conformational changes occur in the IgM-Fc upon antigen binding as part of the signaling function 41, 42 . Our results for IgE-Fc provide support for the notion of an extended IgM-Fc and suggest one way in which a conformational change might occur. Without knowing the structure of the EMPDs that connect the Cε4 domains to the transmembrane regions of the ε-chains, or how the accessory Igα and Igβ chains interact with membrane-IgE or membrane-IgM, it remains a matter for speculation how extended structures might be stabilized. A model for the association between Igα and Cµ4 of IgM has been proposed on the basis of the crystal structure of Igβ 43 , but it is hard to see how interaction with Cµ4 alone could stabilize the extended conformation. Structural studies of the EMPD and the interactions between IgE-Fc and Igα and Igβ are clearly required.
We now consider the nature of the free IgE molecule. The MD analysis shows that the bent conformation exists in a relatively deep energy well (Fig. 2c, conformation 1) and that the rate-limiting step to reaching the extended conformations, and then flipping to the alternative bent conformation with the Cε2 domains packed against the other side of the Fcε3-4, is the escape from this well. Once this occurs, the energy barriers between various extended conformations, including the barrier as the IgE-Fc passes through the linear conformation, are much lower (Fig. 2b,c, conformations 2-4) . Different pathways for unbending may be envisaged, but the most highly populated are expected to have free-energy profiles similar to that sketched in Figure 2c . Although kinetic information may not be directly extracted from the simulations presented here, as biasing forces were applied, an estimate for the rate of unbending may be made if we assume that the process of escape from the well that corresponds to the bent conformation can be described by passage over a single free-energy barrier 26, 44 . The resulting rate of 0.15 s -1 (see Online Methods for equation and parameters used 26, 44 ) must, however, be considered a very approximate calculation. The freeenergy difference between the bent and the various extended states (~8 k B T, Fig. 2c ) implies that only a very small fraction of the molecules occupy an extended conformation at any one time. This is in accord with studies of IgE-Fc in solution 9, 12, 16 , which indicate that the bent conformation predominates.
Comparison of the structures of IgE-Fc or Fcε3-4 with sFcεRIα and sCD23 has shown that, although the binding sites are spatially distinct, occuring at either end of the Cε3 domains 14, 31, 34 , they are allosterically linked such that IgE cannot bind both receptors simultaneously 34 . This mutual exclusion is vital for controlling IgE function. For example, cross-linking of FcεRI-bound IgE by oligomeric CD23 would trigger the allergic response in the absence of allergen. Flexibility in IgE-Fc, in particular the relative disposition of the Cε3 domains, is key to determining their receptor-binding capacity, and therefore understanding this allostery and conformational flexibility is important for targeting IgE's receptor interactions for therapeutic benefit.
We have shown here that aεFab inhibits FcεRI binding both sterically and allosterically (Fig. 5) . Because extended IgE-Fc conformations cannot bind FcεRI, it may be possible to exploit the intrinsic capacity of the molecule to unbend and enhance the dissociation of IgE from the receptor. Indeed, the recent demonstration that accelerated dissociation of IgE from FcεRI can occur upon binding of a DARPin 45 may be explained in terms of the flexibility that we have identified in IgE-Fc. The reported structure of this DARPin complexed with a disulfide-constrained Fcε3-4 (ref. 45) (lacking Cε2 domains) leaves its mechanism of action upon IgE unclear. We do know, however, that the binding of the anti-IgE omalizumab Fab causes a partial unbending of IgE-Fc as monitored by FRET 16 , which may contribute to its mechanism of action. In any event, the discovery that IgE can flex between bent and transiently occupied extended conformations provides a new framework for understanding IgE function in allergen recognition, and offers a more complete description of the structure of this important therapeutic target.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes.
Coordinates and structure factors for aεFab 1 
where F is the observed fluorescence, ∆F n is the fluorescence amplitude change for the nth transient, k obsn is the pseudo-first order rate constant for the nth step and F e is the end-point fluorescence. The bimolecular association rate constants for aεFab 1 (k +1 ) and aεFab 2 (k +2 ) binding were determined by fitting the linear concentration dependences of k obs1 and k obs2 to equation (4):
where k obsn is the pseudo-first order rate constant for the nth transient at the ranges of ligand concentrations used, k +n is the association rate constant for the nth aεFab binding event and k −n is the dissociation rate constant for the nth Fab binding.
FRET. Intramolecular FRET was carried out using IgE-Fc(E289C)-BirA (IgE-Fc with the BirA recognition motif added to the C terminus and biotinylated according to the manufacturer's instructions (Avidity)), labeled with thiol-reactive terbium chelate (Invitrogen) and monovalent streptavidin 67 labeled with aminereactive Alexa488 (Invitrogen), each according to the manufacturer's instructions. Terbium-labeled IgE-Fc and Alexa488-labeled streptavidin were mixed in equi-molar ratios (final assay concentration 25 nM) with aεFab titrated to 30 µM in PBS and incubated for 120 min at room temperature. FRET was measured on an Analyst LJL-HT with excitation 330 nm (80 nm slit width), emission 485 (20 nm slit width) and 520 nm (10 nm slit width). The FRET ratio ((E 520 /E 485 ) × 10 4 ) was plotted as a function of aεFab concentration. Data was fit to a sequential, two-step binding mechanism.
Surface plasmon resonance. SPR experiments were carried out on a Biacore T200 instrument (GE Healthcare). Specific binding surfaces were prepared by coupling aεFab through amine coupling. Coupling density was limited to <500 resonance units. IgE-Fc was injected over the sensor chip at a flow rate of 25 µl min −1 , for 180 s at concentrations of 78, 156, 313, 625, 1,250, 2,500, and 5,000 nM in running buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 5 mM CaCl 2 , and 0.005% (v/v) Surfactant P-20). For sandwich assays, IgE-Fc at 100 nM in running buffer was injected over the sensor chip for 180 s at a flow rate of 25 µl min −1 . At 45 s after completion of IgE-Fc injection, aεFab (at concentrations of 0, 78, 156, 313, 625, 1250, 2,500, and 5,000 nM) or sFcεRIα (at concentrations of 0, 31.2, 62.5, 125, 250, 500, and 1,000 nM) were injected over the chip at a flow rate of 25 µl min −1 for 120 s. Measurements were performed at 25 °C. Double referencing data subtraction methods were performed 68 .
Molecular modeling of whole, extended IgE. FPMOD 69 was used to model whole, extended IgE molecules. The Fab domains from an IgE-like antibody (PDB 2R56) were fused onto the extended IgE-Fc structure, and allowed to move rigidly about a flexible linker until 2,000 models had been generated.
